Found: 23
Select item for more details and to access through your institution.
Tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 177, doi. 10.1007/s11239-019-02026-1
- By:
- Publication type:
- Article
The dawn of aspirin free strategy after short term dual antiplatelet for percutaneous coronary intervention: meta-analysis of randomized controlled trials.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 184, doi. 10.1007/s11239-019-01997-5
- By:
- Publication type:
- Article
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study: A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 192, doi. 10.1007/s11239-019-02014-5
- By:
- Publication type:
- Article
Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 199, doi. 10.1007/s11239-019-01932-8
- By:
- Publication type:
- Article
Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 206, doi. 10.1007/s11239-019-01942-6
- By:
- Publication type:
- Article
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 214, doi. 10.1007/s11239-019-01943-5
- By:
- Publication type:
- Article
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 220, doi. 10.1007/s11239-019-01944-4
- By:
- Publication type:
- Article
Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 228, doi. 10.1007/s11239-019-01970-2
- By:
- Publication type:
- Article
Change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 235, doi. 10.1007/s11239-019-02004-7
- By:
- Publication type:
- Article
Determination of the cut-off prothrombin time to estimate plasma rivaroxaban overdose status.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 245, doi. 10.1007/s11239-019-01947-1
- By:
- Publication type:
- Article
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 251, doi. 10.1007/s11239-019-01956-0
- By:
- Publication type:
- Article
Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 259, doi. 10.1007/s11239-019-01961-3
- By:
- Publication type:
- Article
High incidence of under-treated atrial fibrillation: perspectives from an Asian Stroke Endovascular Thrombectomy Registry.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Direct oral anticoagulants: a review on the current role and scope of reversal agents.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 271, doi. 10.1007/s11239-019-01954-2
- By:
- Publication type:
- Article
Low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 287, doi. 10.1007/s11239-019-01959-x
- By:
- Publication type:
- Article
Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 294, doi. 10.1007/s11239-019-01962-2
- By:
- Publication type:
- Article
Factors associated with women's adherence to postpartum thromboprophylaxis.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 304, doi. 10.1007/s11239-019-01952-4
- By:
- Publication type:
- Article
Congenital fibrinogen disorders with repeated thrombosis.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 312, doi. 10.1007/s11239-019-01958-y
- By:
- Publication type:
- Article
Does telehealth improve anticoagulation management in patient service centers (PSC)? A pilot project.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 316, doi. 10.1007/s11239-019-02031-4
- By:
- Publication type:
- Article
Antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 321, doi. 10.1007/s11239-019-02007-4
- By:
- Publication type:
- Article
The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 325, doi. 10.1007/s11239-019-01949-z
- By:
- Publication type:
- Article
Initiation of a fixed- dose four- factor prothrombin complex concentrate protocol.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2020, v. 49, n. 2, p. 334, doi. 10.1007/s11239-019-01955-1
- By:
- Publication type:
- Article